CVS Health Corp
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.6% | +0.0% | +1.1% | 0.0% | +0.3% | +0.9% | +1.1% | -1.2% | +2.2% | -3.1% | +0.3% | |
| – | -3.3% | -0.6% | +3.7% | -3.7% | +1.9% | +6.6% | +3.4% | +1.9% | -3.1% | +0.1% | +0.7% | |
| – | -37.2% | +19.6% | +27.6% | -45.0% | +24.9% | +17.4% | +17.0% | -22.3% | -7.0% | +12.1% | +18.7% | |
| – | -29.2% | +14.3% | +24.2% | -40.5% | +13.6% | +15.1% | +12.3% | -20.6% | -5.6% | +10.7% | +18.3% | |
| – | +7.0% | -8.5% | +0.5% | +11.7% | +0.8% | +8.7% | +2.6% | +7.9% | -9.3% | +3.0% | -1.7% | |
| – | +0.4% | -9.3% | -1.7% | +9.8% | +2.6% | -4.0% | +0.4% | +8.7% | +1.5% | -7.7% | -0.8% | |
| – | – | – | – | – | -0.1% | -1.3% | -0.8% | -0.8% | -0.2% | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -0.1% | +0.0% | -6.3% | +0.0% | +0.0% | +0.0% | |
| – | -1.3% | -1.6% | -1.6% | -1.7% | -1.8% | -2.8% | -1.3% | -0.9% | -1.8% | -1.7% | -1.7% | |
| – | -2.1% | +1.4% | +1.0% | 0.0% | +0.1% | +0.6% | +1.3% | +0.8% | +1.9% | -5.6% | -0.8% | |
| – | -2.9% | +5.2% | -2.3% | +4.0% | 0.0% | +5.1% | +5.8% | -1.6% | -4.3% | -2.6% | +0.7% | |
| – | +21.7% | +77.3% | -32.5% | +35.1% | -1.7% | +1.1% | +46.5% | -34.8% | -19.8% | -22.8% | -13.6% | |
| – | +0.2% | -7.9% | +5.1% | +9.0% | +1.1% | +4.0% | +4.4% | +253.2% | -2.6% | -71.5% | +1.4% | |
| – | -1.9% | -1.6% | +8.6% | -4.5% | +1.2% | -2.5% | -3.0% | +5.6% | 0.0% | +0.0% | -1.8% | |
| – | +2.9% | -3.3% | +1.3% | +0.0% | +0.8% | +1.8% | +0.6% | -5.8% | +3.1% | +3.0% | +2.9% | |
| – | +2.1% | +0.4% | +1.5% | -1.2% | +1.3% | +1.5% | +0.3% | -7.6% | +3.5% | +3.4% | +3.3% | |
| – | +0.2% | -2.0% | -0.6% | +0.0% | +0.2% | +0.2% | +0.5% | -0.1% | +0.6% | +0.2% | +0.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.